Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma E Wolters

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
EJNMMI Research|August 17, 2018
A novel partial volume correction method for accurate quantification of [<sup>18</sup>F] flortaucipir in the hippocampusEmma E Wolters, Sandeep S V Golla, Tessa Timmers, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 11, 2020
Correction to: Regional [<sup>18</sup>F]flortaucipir PET is more closely associated with disease severity than CSF p-tau in Alzheimer's diseaseEmma E Wolters, Rik Ossenkoppele, Sander C J Verfaillie, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|December 21, 2018
Parametric methods for [<sup>18</sup>F]flortaucipir PETSandeep Sv Golla, Emma E Wolters, Tessa Timmers, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 16, 2020
Regional [<sup>18</sup>F]flortaucipir PET is more closely associated with disease severity than CSF p-tau in Alzheimer's diseaseEmma E Wolters, Rik Ossenkoppele, Sander C J Verfaillie, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 13, 2022
A Head-to-Head Comparison Between Plasma pTau181 and Tau PET Along the Alzheimer's Disease ContinuumEmma M Coomans, Inge M W Verberk, Rik Ossenkoppele, et al.
Neurobiology of Aging|April 27, 2019
Amyloid PET and cognitive decline in cognitively normal individuals: the SCIENCe projectTessa Timmers, Rik Ossenkoppele, Sander C J Verfaillie, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 21, 2021
Correction to: The Strategic Biomarker Roadmap for the validation of Alzheimer's diagnostic biomarkers: methodological updateMarina Boccardi, Alessandra Dodich, Emiliano Albanese, et al.
Brain : a Journal of Neurology|January 13, 2022
Genetically identical twins show comparable tau PET load and spatial distributionEmma M Coomans, Jori Tomassen, Rik Ossenkoppele, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 10, 2021
The strategic biomarker roadmap for the validation of Alzheimer's diagnostic biomarkers: methodological updateMarina Boccardi, Alessandra Dodich, Emiliano Albanese, et al.
Alzheimer'S Research & Therapy|February 6, 2021
In vivo tau pathology is associated with synaptic loss and altered synaptic functionEmma M Coomans, Deborah N Schoonhoven, Hayel Tuncel, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
EJNMMI Research|August 17, 2018
A novel partial volume correction method for accurate quantification of [<sup>18</sup>F] flortaucipir in the hippocampusEmma E Wolters, Sandeep S V Golla, Tessa Timmers, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 11, 2020
Correction to: Regional [<sup>18</sup>F]flortaucipir PET is more closely associated with disease severity than CSF p-tau in Alzheimer's diseaseEmma E Wolters, Rik Ossenkoppele, Sander C J Verfaillie, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|December 21, 2018
Parametric methods for [<sup>18</sup>F]flortaucipir PETSandeep Sv Golla, Emma E Wolters, Tessa Timmers, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 16, 2020
Regional [<sup>18</sup>F]flortaucipir PET is more closely associated with disease severity than CSF p-tau in Alzheimer's diseaseEmma E Wolters, Rik Ossenkoppele, Sander C J Verfaillie, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 13, 2022
A Head-to-Head Comparison Between Plasma pTau181 and Tau PET Along the Alzheimer's Disease ContinuumEmma M Coomans, Inge M W Verberk, Rik Ossenkoppele, et al.
Neurobiology of Aging|April 27, 2019
Amyloid PET and cognitive decline in cognitively normal individuals: the SCIENCe projectTessa Timmers, Rik Ossenkoppele, Sander C J Verfaillie, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 21, 2021
Correction to: The Strategic Biomarker Roadmap for the validation of Alzheimer's diagnostic biomarkers: methodological updateMarina Boccardi, Alessandra Dodich, Emiliano Albanese, et al.
Brain : a Journal of Neurology|January 13, 2022
Genetically identical twins show comparable tau PET load and spatial distributionEmma M Coomans, Jori Tomassen, Rik Ossenkoppele, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 10, 2021
The strategic biomarker roadmap for the validation of Alzheimer's diagnostic biomarkers: methodological updateMarina Boccardi, Alessandra Dodich, Emiliano Albanese, et al.
Alzheimer'S Research & Therapy|February 6, 2021
In vivo tau pathology is associated with synaptic loss and altered synaptic functionEmma M Coomans, Deborah N Schoonhoven, Hayel Tuncel, et al.
Pageof 3